GLP-1 drugs like Ozempic have swept the world as effective therapies for far more than their original target of diabetes.

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.

As certain weight-loss drugs have become increasingly popular, scammers are taking notice and coming out of the woodwork to ...

Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the ...